The canonical tumor suppressor, Merlin (NF2), has been shown to regulate the function and activity of cell surface receptor tyrosine kinases, modulating “outside-in” signaling to control contact-induced inhibition of proliferation and tumor progression in various cancer types (20–22). Here, NF2 is linked to neoplasm.